Corneal Cross-Linking (CXL) vs. Other Treatments: Which Is Right for You?

A woman with keratoconus holds a basketball on the court after playing a game glasses-free.

A keratoconus diagnosis often comes with a wave of uncertainty. Many patients find themselves asking the same questions. What happens next? Will my vision keep getting worse? Which treatment is the best choice?

The truth is, there is no single “best” solution for keratoconus. There is only the right combination of treatments at the right time.

At the CLEI Center for Keratoconus, the focus is not just on treating keratoconus once. It is on providing personalized, lifelong care that protects vision and supports quality of life at every stage.

Understanding Keratoconus and Its Progression

Keratoconus (KC) is a condition that affects the structure of the cornea. Instead of maintaining its natural round shape, the cornea gradually thins and bulges outward into a cone-like shape. This irregularity distorts light as it enters the eye, leading to blurry, fluctuating, or distorted vision.

One of the most challenging aspects of keratoconus is that it does not progress the same way for everyone. Some patients experience rapid changes early on, while others may have slow or minimal progression over many years.

This variability is why keratoconus treatment options must be tailored to each individual. The right approach depends on:

  • Stage of the condition
  • Stability of the cornea
  • Age and risk of progression
  • Lifestyle needs
  • Personal vision goals

Understanding these factors is key when considering options like corneal crosslinking, specialty lenses, or surgical procedures.

What Is Corneal Cross-Linking (CXL)?

When patients ask what is corneal cross linking, the simplest answer is this: it is a treatment designed to strengthen the cornea and slow or stop keratoconus from getting worse.

How CXL Works

Corneal crosslinking works by reinforcing the internal structure of the cornea. Using a combination of riboflavin (vitamin B2) eye drops and controlled ultraviolet light, new bonds form between collagen fibers in the cornea.

This makes the cornea more stable and less likely to continue bulging.

What CXL Does

Corneal crosslinking is primarily a stabilizing treatment. Its main goal is to slow or halt progression of keratoconus.

What CXL Does Not Do

CXL usually does not improve vision on its own. It helps preserve the cornea’s shape but does not typically eliminate the need for visual correction.

Who Is a Good Candidate for CXL?

CXL is often recommended for patients with:

  • Early to moderate keratoconus
  • High risk of worsening over time

Younger patients are more likely to experience progression, which makes early intervention especially important. However, adults with changing corneas may also benefit from treatment.

Other Keratoconus Treatments (And What They Do Best)

While corneal crosslinking plays an important role, it is often just one part of a larger plan.

Specialty Contact Lenses for Keratoconus

Specialty contact lenses are designed to improve functional vision by creating a smooth optical surface over the irregular cornea.

Common options include:

  • Scleral lenses
  • Hybrid lenses
  • RGP (rigid gas permeable) lenses

Even after CXL stabilizes the cornea, many patients rely on these lenses for clear, comfortable vision.

Topography-Guided and Vision-Correcting Procedures

Some keratoconus treatments are designed not just to stabilize the condition, but to improve how well you see.

Procedures such as topography-guided PRK and implantable lens options like EVO ICL are customized to work with irregular corneas rather than against them. These approaches use detailed corneal mapping to create more precise visual correction tailored to each patient’s unique shape.

Unlike corneal crosslinking, which focuses on slowing disease progression, these treatments aim to optimize vision. In the right candidates, they can reduce distortion, improve clarity, and lessen dependence on specialty contact lenses.

In many cases, these procedures are performed after the cornea has been stabilized with CXL, creating a powerful combination that addresses both the underlying condition and visual performance.

CTAK

Corneal Tissue Addition Keratoplasty (CTAK) can improve vision in mild to moderate keratoconus by reshaping the cornea.

This innovative procedure was developed at CLEI and offers a vision-enhancing option for patients who may not need more invasive surgery.

Corneal Transplants

In advanced cases, particularly when scarring is present, corneal transplantation may be necessary.

However, modern keratoconus treatments like CXL and CTAK now allow many patients to delay or avoid transplant altogether.

CXL vs. Other Treatments: It’s Not Either/Or

A common misconception is that patients must choose between corneal crosslinking and other treatments. In reality, combination care often provides the best outcomes.

Why Combination Treatment Is Often Best

CXL stabilizes the cornea. Lenses and reshaping procedures restore usable vision. Both are essential for long-term success. Treatment strategies may include:

  • CXL plus specialty lenses
  • CXL plus CTAK
  • Sequential or simultaneous procedures

How CLEI Approaches Keratoconus Differently

A Full Spectrum of Care

CLEI provides access to nearly every modern keratoconus treatment option in one place.

Their KC 1,2,3 philosophy focuses on:

  1. Stability
  2. Corneal reshaping
  3. Vision correction

This approach allows for customized care rather than a one-size-fits-all protocol.

Top Specialists and Advanced Diagnostics

Fellowship-trained, keratoconus-focused doctors use advanced imaging and monitoring tools to track even subtle changes in the cornea.

Custom Treatment Plans

Decisions are based on progression, lifestyle, work demands, and comfort. Treatment plans evolve as keratoconus changes over time.

A Lifelong Approach to Keratoconus Care

Keratoconus management does not end after one procedure. Ongoing monitoring allows doctors to adjust care as needed and helps patients maintain clear, comfortable vision over time. The goal is not just better test results. It is greater independence and confidence in daily life.

Quality of Life Matters

Effective keratoconus care supports:

Equally important is the emotional relief that comes from having a long-term plan.

Frequently Asked Questions

Is CXL enough on its own?

CXL stabilizes keratoconus but usually does not fully correct vision. Many patients still benefit from specialty contact lenses or additional procedures.

Can I still need contacts after CXL?

Yes. Specialty lenses often remain essential for achieving the best visual clarity.

What’s the difference between epi-on and epi-off CXL?

Epi-off removes the corneal surface layer before treatment and has been widely used for years.
Epi-on keeps the surface intact and may offer a more comfortable recovery. New options, including FDA-approved Epioxa and ongoing clinical trials, are expanding treatment possibilities.

What if my KC progresses later in life?

Progression can occur at any age. Regular monitoring helps ensure timely intervention if changes arise.

How do doctors decide which treatments to combine?

Doctors evaluate progression risk, corneal shape, vision needs, and lifestyle factors to create a personalized plan.

Final Thoughts: The Right Treatment Is the One Built Around You

Keratoconus care is a journey, not a single decision. The best outcomes come from experienced providers who offer comprehensive care and understand how to combine treatments effectively. CLEI is committed to delivering customized, lifelong vision solutions designed around each patient’s needs and goals. 

If you are ready to receive comprehensive keratoconus care, schedule an appointment with us today.

Ready to See Clearly?
Let’s Talk.

Related Articles

request a free consultation
request appointment
contact us

Ready to See Clearly?
Let’s Talk.